Literature DB >> 16376585

Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells.

Mingxin Shi1, Qiufeng Cai, Luming Yao, Yubin Mao, Yanlin Ming, Gaoliang Ouyang.   

Abstract

Curcumin, an active ingredient from the rhizome of the plant, Curcuma longa, has antioxidant, anti-inflammatory and anti-cancer activities. It has recently been demonstrated that the chemopreventive activities of curcumin might be due to its ability to inhibit cell growth and induce apoptosis. In the present study, we have investigated the effects of curcumin on growth and apoptosis in the human ovarian cancer cell line Ho-8910 by MTT assay, fluorescence microscopy, flow cytometry and Western blotting. Our data revealed that curcumin could significantly inhibit the growth and induce apoptosis in Ho-8910 cells. A decrease in expression of Bcl-2, Bcl-X(L) and pro-caspase-3 was observed after exposure to 40 microM curcumin, while the levels of p53 and Bax were increased in the curcumin-treated cells. These activities may contribute to the anticarcinogenic action of curcumin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16376585     DOI: 10.1016/j.cellbi.2005.10.024

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  36 in total

1.  Sphingosine kinase-1 inhibition sensitizes curcumin-induced growth inhibition and apoptosis in ovarian cancer cells.

Authors:  Yan-li Yang; Chao Ji; Lei Cheng; Li He; Chun-cheng Lu; Rong Wang; Zhi-gang Bi
Journal:  Cancer Sci       Date:  2012-07-10       Impact factor: 6.716

2.  Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles.

Authors:  Aysegul Altunbas; Seung J Lee; Sigrid A Rajasekaran; Joel P Schneider; Darrin J Pochan
Journal:  Biomaterials       Date:  2011-05-23       Impact factor: 12.479

3.  Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways.

Authors:  Hong Zong; Feng Wang; Qing-Xia Fan; Liu-Xing Wang
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

4.  Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia.

Authors:  Puneet Rinwa; Baljinder Kaur; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-06       Impact factor: 3.000

5.  Curcumin suppresses colon cancer cell invasion via AMPK-induced inhibition of NF-κB, uPA activator and MMP9.

Authors:  Weihua Tong; Quan Wang; Donghui Sun; Jian Suo
Journal:  Oncol Lett       Date:  2016-09-16       Impact factor: 2.967

6.  Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells.

Authors:  Jin-bo Wang; Li-li Qi; Shui-di Zheng; Tian-xing Wu
Journal:  J Zhejiang Univ Sci B       Date:  2009-02       Impact factor: 3.066

7.  Modulation of carbohydrate metabolism during N-methyl N-nitrosourea induced neurotoxicity in mice: role of curcumin.

Authors:  Neha Singla; D K Dhawan
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

8.  Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells.

Authors:  Lauren Friedman; Li Lin; Sarah Ball; Tanios Bekaii-Saab; James Fuchs; Pui-Kai Li; Chenglong Li; Jiayuh Lin
Journal:  Anticancer Drugs       Date:  2009-07       Impact factor: 2.248

9.  A preliminary study of apoptosis induction in glioma cells via alteration of the Bax/Bcl-2-p53 axis by transformed and non-transformed root extracts of Leonurus sibiricus L.

Authors:  Przemysław Sitarek; Ewa Skała; Monika Toma; Marzena Wielanek; Janusz Szemraj; Malgorzata Nieborowska-Skorska; Maciej Kolasa; Tomasz Skorski; Halina Wysokińska; Tomasz Śliwiński
Journal:  Tumour Biol       Date:  2016-01-07

10.  New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells.

Authors:  Ling Cen; Brian Hutzen; Sarah Ball; Stephanie DeAngelis; Chun-Liang Chen; James R Fuchs; Chenglong Li; Pui-Kai Li; Jiayuh Lin
Journal:  BMC Cancer       Date:  2009-03-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.